NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/17/2025
Back to search
Official data from USPTO
LIMULUS BIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LIMULUS BIO
ST13
US500000079319782Class
35, 41, 42, 45
Filing
79319782
Registration
6784221
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
07/18/2025
Trademark type
Word
Nice classes
35, 41, 42, 45
Filing date
01/22/2021
Registration date
07/12/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/12/2022
Last transaction
07/18/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
64
Owner location
SE
Examiner
LOBO, DEBORAH
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Limulus Bio AB
Representatives
John Alumit ALUMIT IP
Technical classification
Nice Classes
Class 35Class 41Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Data management services in the field of biocompatibilitytoxicologymedical engineeringpharmacologychemical characterisation and development of medical equipment and devices; computerised database management and data processing in the field of medical engineering and devices
Class 41
Education servicesteaching and training in the fields of medical equipment and devicesbiocompatibility and toxicology; education servicesteaching and training relating to biocompatibilitytoxicologypharmacology and chemical characterization in the fields of medical equipment; publication of medical technical texts and approval documentation in the fields of medical engineering; publication of statistical and clinical reports in the fields of medical engineeringpharmacology and devicesbiocompatibility and toxicology
Class 42
Conducting of scientific biocompatibility studies and research in the fields of biocompatibilitytoxicologypharmacology and chemical characterization; research and testing in the fields of biocompatibilitytoxicologypharmacology and chemical characterization; consultancy relating to product development in the fields of medical equipment and devicesbiocompatibility and toxicology; scientific servicesconducting of clinical studies and research in the fields of medical equipment and devicesbiocompatibility and toxicology
Class 45
Consultancy relating to regulatory compliance and validation procedures for assuring regulatory compliance relating to biocompatibilitytoxicologymedical engineering pharmacology and chemical characterization; providing information in the field of regulation about examination and approval processes of regulatory bodies and authorities and registered bodies in the fields of biocompatibilitytoxicologymedical engineeringpharmacology and chemical characterization
Publications
History of USPTO decisions and trademark events.
38 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/20/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/15/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/02/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/02/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/14/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/21/2022
FIMP
FINAL DISPOSITION PROCESSED
10/21/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/12/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/12/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
07/12/2022
GPNX
NOTIFICATION PROCESSED BY IB
05/03/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/26/2022
PUBO
PUBLISHED FOR OPPOSITION
04/26/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/13/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/13/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/09/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/06/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/25/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/23/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/23/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/22/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/22/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/23/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/23/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/23/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/23/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/23/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/23/2022
RFNT
REFUSAL PROCESSED BY IB
10/30/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/01/2021
RFRR
REFUSAL PROCESSED BY MPU
10/01/2021
MAFR
APPLICATION FILING RECEIPT MAILED
09/17/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/16/2021
CNRT
NON-FINAL ACTION WRITTEN
09/15/2021
DOCK
ASSIGNED TO EXAMINER
09/13/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/13/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/09/2021
Continuous trademark protection
Get notified about every new filing that threatens LIMULUS BIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.